Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Falchi L., Nijland M., Huang H., Linton K. M., Seymour J. F., Tao R., ...More

Lancet (London, England), vol.407, no.10524, pp.161-173, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 407 Issue: 10524
  • Publication Date: 2026
  • Doi Number: 10.1016/s0140-6736(25)02360-8
  • Journal Name: Lancet (London, England)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, Artic & Antarctic Regions, BIOSIS, CINAHL, EMBASE, MEDLINE, Psycinfo, Public Affairs Index, Nature Index
  • Page Numbers: pp.161-173
  • Ankara University Affiliated: Yes

Abstract

This paper has been written to mark 25 years of operational medium-range ensemble forecasting. The origins of the ECMWF Ensemble Prediction System are outlined, including the development of the precursor real-time Met Office monthly ensemble forecast system. In particular, the reasons for the development of singular vectors and stochastic physics - particular features of the ECMWF Ensemble Prediction System - are discussed. The author speculates about the development and use of ensemble prediction in the next 25 years.